|
2022
|
Invention
|
Compounds and methods for regulating insulin secretion.
Disclosed herein are methods for inducin... |
|
2021
|
Invention
|
Compositions and methods related to bicyclo[2.2.1] heptanamine-containing compounds.
The present... |
|
|
Invention
|
Compositions and methods related to di-substituted bicyclo[2.2.1] heptanamine-containing compound... |
|
|
Invention
|
Compositions and methods related to bicyclo[2.2.1] heptanamine-containing compounds. The present ... |
|
|
Invention
|
Agents for reversing toxic proteinopathies. The present disclosure relates to compositions and me... |
|
2019
|
Invention
|
Aryl hydrocarbon receptor (ahr) activator compounds as cancer therapeutics.
The present disclosu... |
|
|
Invention
|
Use of disulfiram and other compounds to treat cancers with loss of chromosome 16q and/or low exp... |
|
|
Invention
|
Vanadium compositions and methods for treatment of cancer.
The present disclosure relates to com... |
|
|
Invention
|
Tepoxalin targeting of abcb1 overexpressing cancers.
The present disclosure relates to compositi... |
|
|
Invention
|
Targeting egln1 in cancer.
The present disclosure relates to compositions and methods for the di... |
|
|
Invention
|
Therapeutic treatment of microsatellite unstable cancers.
The present disclosure relates to comp... |
|
2018
|
Invention
|
Compounds and methods for regulating insulin secretion. Disclosed herein are methods for inducing... |
|
2017
|
Invention
|
Propeptide-luciferase fusion proteins and methods of use thereof. The present invention provides ... |
|
2016
|
Invention
|
Compositions and methods for targeting cancer-specific sequence variations. The present invention... |
|
2015
|
Invention
|
Methods of diagnosing and treating medullary cystic kidney disease. The present invention feature... |
|
2012
|
Invention
|
Compositions and methods of treating head and neck cancer. The present invention provides methods... |
